Atrial Fibrillation Trial, Recruiting NCT07630857 Sponsor: China National Center for Cardiovascular Diseases Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07630857
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged between 18 and 80 years old
  • People who have a confirmed diagnosis of atrial fibrillation (an irregular heart rhythm), either the type that comes and goes or the type that stays for longer periods
  • People who are already scheduled to have a catheter ablation procedure for their atrial fibrillation, including those who have had a previous ablation but whose atrial fibrillation has returned
  • People who are willing and able to sign a consent form agreeing to take part
  • People who are able to attend a follow-up appointment 3 months after their procedure

Who may not be able to join:

  • People whose heart's pumping strength is below a certain level (a measurement called ejection fraction below 35%) (confirm with trial site)
  • People with serious heart valve problems, specifically moderate to severe narrowing or leaking of the mitral valve
  • People who have previously had a blood clot inside their heart
  • People for whom blood-thinning medications are not a safe option
  • People who currently have an active infection or blood infection (sepsis)
  • People who are pregnant or breastfeeding
  • People who have another serious illness that means their life expectancy is less than 12 months
  • People who have taken part in another interventional clinical trial within the 30 days before enrolling in this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8618811592092

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
China National Center for Cardiovascular Diseases
Registry
ClinicalTrials.gov
Start date
20 June 2026
Est. completion
19 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Freedom from Atrial Fibrillation Recurrence at 3 Months Post Ablation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov